Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL.

Saved in:
Bibliographic Details
Title: Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL.
Authors: Zhao Y; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.; Center of Excellence for Leukemia Studies, St. Jude Children's Research Hospital, Memphis, TN., Short NJ; Department of Leukemia, MD Anderson Cancer Center, Houston, TX., Kantarjian HM; Department of Leukemia, MD Anderson Cancer Center, Houston, TX., Chang TC; Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN., Ghate PS; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.; Center of Excellence for Leukemia Studies, St. Jude Children's Research Hospital, Memphis, TN., Qu C; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.; Center of Excellence for Leukemia Studies, St. Jude Children's Research Hospital, Memphis, TN., Macaron W; Department of Leukemia, MD Anderson Cancer Center, Houston, TX., Jain N; Department of Leukemia, MD Anderson Cancer Center, Houston, TX., Thakral B; Department of Hematopathology, MD Anderson Cancer Center, Houston, TX., Phillips AH; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN., Khoury J; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE., Garcia-Manero G; Department of Leukemia, MD Anderson Cancer Center, Houston, TX., Zhang W; Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN., Fan Y; Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN., Yang H; Department of Leukemia, MD Anderson Cancer Center, Houston, TX., Garris RS; Department of Leukemia, MD Anderson Cancer Center, Houston, TX., Nasr LF; Department of Leukemia, MD Anderson Cancer Center, Houston, TX., Kriwacki RW; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN., Roberts KG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.; Center of Excellence for Leukemia Studies, St. Jude Children's Research Hospital, Memphis, TN., Konopleva M; Department of Oncology and Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY., Jabbour EJ; Department of Leukemia, MD Anderson Cancer Center, Houston, TX., Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.; Center of Excellence for Leukemia Studies, St. Jude Children's Research Hospital, Memphis, TN.
Source: Blood [Blood] 2024 Jul 04; Vol. 144 (1), pp. 61-73.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first